Literature DB >> 8143370

Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels.

K Nakajima1, T Saito, A Tamura, M Suzuki, T Nakano, M Adachi, A Tanaka, N Tada, H Nakamura, E Campos.   

Abstract

We have developed a simple, rapid assay method for apo E-rich lipoproteins (d < 1.006 g/ml), using an immunoaffinity gel mixture of anti apo B-100 and apo A-I antibodies coupled to Sepharose 4B. The immunoaffinity mixed gels adsorb normal lipoproteins containing apo A-I quantitatively as well as most lipoproteins containing apo B-100. Unbound lipoproteins are quantified by assay of cholesterol. Characterization of the unbound lipoproteins of d < 1.006 g/ml (J Lipid Res 1992; 33: 369-380) has shown that they represent chylomicron and VLDL remnant-like particles (RLP). RLP-Cholesterol(C) levels in plasma have been determined in 363 male and female normolipidemic subjects (mean +/- S.D.: 72 +/- 16 mg/l) and have been found to be higher in patients with coronary heart disease and familial dysbetalipoproteinemia. Triglyceride-rich lipoproteins may well contain both atherogenic and non-atherogenic particles that can be separated by this simple immunoadsorption assay.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8143370     DOI: 10.1016/0009-8981(93)90062-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  40 in total

1.  Effect of a low-fat diet enriched with oleic acid on postprandial lipemia in patients with type 2 diabetes mellitus.

Authors:  K Higashi; H Shige; T Ito; K Nakajima; T Ishikawa; H Nakamura; F Ohsuzu
Journal:  Lipids       Date:  2001-01       Impact factor: 1.880

2.  Lipoproteins: When size really matters.

Authors:  J Bruce German; Jennifer T Smilowitz; Angela M Zivkovic
Journal:  Curr Opin Colloid Interface Sci       Date:  2006-06       Impact factor: 6.448

Review 3.  Postprandial lipoprotein metabolism: VLDL vs chylomicrons.

Authors:  Katsuyuki Nakajima; Takamitsu Nakano; Yoshiharu Tokita; Takeaki Nagamine; Akihiro Inazu; Junji Kobayashi; Hiroshi Mabuchi; Kimber L Stanhope; Peter J Havel; Mitsuyo Okazaki; Masumi Ai; Akira Tanaka
Journal:  Clin Chim Acta       Date:  2011-04-19       Impact factor: 3.786

4.  A new enzyme-linked immunosorbent assay system for human serum hepatic triglyceride lipase.

Authors:  Kazuya Miyashita; Katsuyuki Nakajima; Isamu Fukamachi; Yuji Muraba; Takafumi Koga; Yohnosuke Shimomura; Tetsuyo Machida; Masami Murakami; Junji Kobayashi
Journal:  J Lipid Res       Date:  2017-06-20       Impact factor: 5.922

Review 5.  Remnant lipoproteins and atherosclerosis.

Authors:  ThB Twickler; G M Dallinga-Thie; M J Chapman; J S Cohn
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

6.  Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease.

Authors:  G T Russo; A Giandalia; E L Romeo; M Marotta; A Alibrandi; C De Francesco; K V Horvath; B Asztalos; D Cucinotta
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

Review 7.  The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.

Authors:  Pratik B Sandesara; Salim S Virani; Sergio Fazio; Michael D Shapiro
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

8.  Extreme Contrast of Postprandial Remnant-Like Particles Formed in Abetalipoproteinemia and Homozygous Familial Hypobetalipoproteinemia.

Authors:  Masa-Aki Kawashiri; Hayato Tada; Marowa Hashimoto; Matsuo Taniyama; Takamitsu Nakano; Katsuyuki Nakajima; Takeshi Inoue; Mika Mori; Chiaki Nakanishi; Tetsuo Konno; Kenshi Hayashi; Atsushi Nohara; Akihiro Inazu; Junji Koizumi; Hirotaka Ishihara; Junji Kobayashi; Tsutomu Hirano; Hiroshi Mabuchi; Masakazu Yamagishi
Journal:  JIMD Rep       Date:  2015-03-13

9.  Effects of nateglinide on the elevation of postprandial remnant-like particle triglyceride levels in Japanese patients with type 2 diabetes assessment by meal tolerance test.

Authors:  Yutaka Mori; Genshin Kuriyama; Naoko Tajima
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

10.  n-3 long-chain FA decrease serum levels of TG and remnant-like particle-cholesterol in humans.

Authors:  Kei Hamazaki; Miho Itomura; Mingming Huan; Hiroto Nishizawa; Shiro Watanabe; Tomohito Hamazaki; Shigeki Sawazaki; Katsutoshi Terasawa; Shuuji Nakajima; Takashi Terano; Yoshiya Hata; Seiichi Fujishiro
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.